Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-16 12:24 pm Sale | 2026-09-30 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Janus Henderson Group Ltd. JHG | 6,318,050 7.200% | -790,438![]() (-11.12%) | Filing History |
| 2026-10-16 5:58 pm Purchase | 2026-10-14 | 13D | OLEMA PHARMACEUTICALS INC OLMA | BIOTECHNOLOGY VALUE FUND L P | 8,939,731 9.800% | 1,382,494![]() (+18.29%) | Filing History |
| 2026-08-06 10:33 am Purchase | 2026-06-30 | 13G | OLEMA PHARMACEUTICALS INC OLMA | FMR LLC | 12,075,062 13.800% | 2,077,002![]() (+20.77%) | Filing History |
| 2026-07-29 3:19 pm Purchase | 2026-06-30 | 13G | OLEMA PHARMACEUTICALS INC OLMA | BlackRock Inc. BLK | 6,244,212 7.100% | 2,980,305![]() (+91.31%) | Filing History |
| 2026-05-15 4:30 pm Sale | 2026-03-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Bain Capital Life Sciences Opportunities IV, L.P. | 7,473,238 8.150% | -1,035,403![]() (-12.17%) | Filing History |
| 2026-05-15 12:38 pm Purchase | 2026-03-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Janus Henderson Group Ltd. JHG | 7,108,488 8.200% | 398,294![]() (+5.94%) | Filing History |
| 2026-03-20 10:37 am Purchase | 2026-03-16 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Invus Public Equities, L.P. | 4,461,949 5.100% | 4,461,949![]() (New Position) | Filing History |
| 2026-03-06 10:05 am Purchase | 2026-02-27 | 13G | OLEMA PHARMACEUTICALS INC OLMA | FMR LLC | 9,998,060 12.500% | 4,974,968![]() (+99.04%) | Filing History |
| 2026-02-17 4:34 pm Purchase | 2025-12-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Janus Henderson Group Ltd. JHG | 6,710,194 8.400% | 3,124,345![]() (+87.13%) | Filing History |
| 2026-02-17 4:30 pm Purchase | 2025-12-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Bain Capital Life Sciences Opportunities IV, L.P. | 8,508,641 9.990% | 1,664,687![]() (+24.32%) | Filing History |
| 2026-02-13 08:49 am Sale | 2025-12-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Deep Track Capital, LP | 0 0.000% | -3,442,833![]() (Position Closed) | Filing History |
| 2026-02-05 1:31 pm Purchase | 2025-12-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | FMR LLC | 5,023,092 6.300% | 5,023,092![]() (New Position) | Filing History |
| 2025-11-14 10:29 am Purchase | 2025-09-30 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Janus Henderson Group Ltd. JHG | 3,585,849 5.200% | 2,885,749![]() (+412.19%) | Filing History |
| 2025-05-15 3:51 pm Sale | 2025-03-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Point72 Asset Management, L.P. | 1,543,931 2.300% | -1,681,319![]() (-52.13%) | Filing History |
| 2025-05-15 08:46 am Sale | 2025-03-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Deep Track Capital, LP | 3,442,833 5.040% | -557,167![]() (-13.93%) | Filing History |
| 2025-05-15 07:00 am Sale | 2025-03-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Bain Capital Life Sciences Opportunities IV, L.P. | 6,843,954 9.990% | -251,826![]() (-3.55%) | Filing History |
| 2025-05-13 7:29 pm Sale | 2025-03-18 | 13D | OLEMA PHARMACEUTICALS INC OLMA | Logos Global Management LP | 3,208,875 4.700% | -39,943![]() (-1.23%) | Filing History |
| 2025-04-15 5:04 pm Purchase | 2025-03-31 | 13G | IVANHOE ELEC INC IE | BlackRock Portfolio Management LLC | 7,849,151 5.900% | 7,849,151![]() (New Position) | Filing History |
| 2025-02-14 4:45 pm Purchase | 2024-12-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Paradigm BioCapital Advisors LP | 7,429,355 9.990% | 1,925,755![]() (+34.99%) | Filing History |
| 2025-01-13 4:24 pm Sale | 2025-01-08 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Bain Capital Life Sciences Opportunities IV, L.P. | 7,095,780 9.990% | -374,434![]() (-5.01%) | Filing History |

